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MaTranscatheter mitral valve implantation (TMVI) represents a promising approach to treating mitral valve regurgi-
tation in patients at increased risk of perioperative mortality. Similar to transcatheter aortic valve replacement
(TAVR), TMVI relies on pre- and periprocedural noninvasive imaging. Although these imaging modalities, namely
echocardiography, computed tomography, and ﬂuoroscopy, are well established in TAVR, TMVI has entirely different
requirements. Approaches and nomenclature need to be standardized given the multiple disciplines involved. Herein
we provide an overview of anatomical principles and deﬁnitions, a methodology for anatomical quantiﬁcation, and
perioperative guidance. (J Am Coll Cardiol Img 2015;8:1191–208) © 2015 by the American College of Cardiology
Foundation.S urgical mitral valve repair or replacement arestandard therapies for mitral regurgitation(MR), however, many elderly patients with clin-
ically signiﬁcantMR are deemed too high risk for surgi-
cal intervention (1) and are often precluded from
surgical treatment (2,3). Percutaneous repair strate-
gies are under investigation as alternative options in
high-risk populations (4,5). More recently, transcath-
eter mitral valve implantation (TMVI) has been pro-
posed in a fashion analogous to transcatheter aortic
valve replacement (TAVR) with promising early
results (6–9). Building on experience with TAVR,
advanced imaging has undergone much earlier inte-
gration in TMVI (10,11). Given the complex structure
and function of the mitral valve (MV), with its
nonplanar annulus; the lack of a circular, ﬁbrous
annular structure; the variability of leaﬂet and sub-
valvular apparatus anatomy and its proximity to the
left ventricular outﬂow tract (LVOT), the role of imag-
ing is possibly even more pertinent (12).
We highlight the important anatomical and
noninvasive imaging issues that are essential for
successfully performing TMVI and emphasize the
common nomenclature for use among various imag-
ing modalities and specialties (Tables 1 and 2, Central
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TMVI DEVICES
TMVI currently in human trials target treatment of
both primary MR (i.e., degenerative mitral valve dis-
ease [DMVD]) (6,9) and secondary MR (i.e., functional
mitral regurgitation [FMR]) (6–8) with some devices
intended to treat both disease entities (6,9).
An initial attempt at transvenous transseptal im-
plantation proved difﬁcult and has not yet been
attempted again in humans (12). Subsequently,
transapical access has been successful and is being
pursued, with all valves currently in human trials
(6–9), although a transseptal approach is regarded as
the major aim of efforts in innovation.
All devices under investigation incorporate certain
common features: a transapical access system, a
nitinol self-expanding frame, bovine pericardial tri-
leaﬂet valve, and a fabric or pericardial sealing cuff
(12). Some devices are circular (8,9), whereas others
are D-shaped (6,7), in which the latter has the ﬂat
portion of the frame oriented toward the anterior
mitral valve leaﬂet (AML) in order to reduce the po-
tential for LVOT obstruction. The bioprosthetic
valvular apparatus consists of 3 symmetrical leaﬂets
(6,8,9), with the exception of 1 device, which hasships with Echo Core Lab, Valtech Cardio, and Ten-
dical; and is a HighLife shareholder. Dr. Leipsic is a
ces for Edwards Lifesciences, Neovasc, and Tendyne.
the contents of this paper to disclose.
2015, accepted August 13, 2015.
AB BR E V I A T I O N S
AND ACRONYM S
AML = anterior mitral valve
leaﬂet
CT = computed tomography
FMR = functional mitral
regurgitation
LV = left ventricle
LVOT = left ventricular
outﬂow tract
MA = mitral annulus
MR = mitral regurgitation
PML = posterior mitral leaﬂet
TEE = transesophageal
echocardiography
TTE = transthoracic
echocardiography
TAVR = transcatheter aortic
valve replacement
TMVI = transcatheter mitral
valve implantation
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1193asymmetrical leaﬂets with a posterior leaﬂet that is
slightly larger than its 2 anterior leaﬂets (7).
Most devices incorporate a wide atrial skirt or
ﬂange, which is in direct apposition to the left atrial
wall surrounding the mitral inﬂow to assist with
device capture and sealing (7–9). Importantly, none
of the devices relies primarily on radial force for
ﬁxation. Fixation is facilitated either by tabs which
engage with the basal myocardium and ﬁbrous
skeleton (7), opposing, circumferential anchors to
engage with the annulus and leaﬂets (9), paddles for
leaﬂet capturing at the A2/P2 scallops (8), or an
apical tether (6). The anchoring mechanisms are the
most distinguishing characteristic among the devices
(Figures 1 and 2) and largely determine anatomical
requirements such as landing-zone characteristics,
which may differ signiﬁcantly between mitral pa-
thologies and patients.
MITRAL APPARATUS
The MV complex is composed of the annulus, the
anterior and posterior leaﬂets, chordae tendinae, and
papillary muscles.
MITRAL ANNULUS. Historically, the mitral annulus
(MA) is deﬁned by the junction of the left atrium, left
ventricle (LV), and mitral leaﬂets, resulting in a 3-
dimensional (3D) saddle-shaped conﬁguration with
anterior and posterior peaks (13), the former being
continuous with the aortovalvular complex, the latter
formed by the insertion of the posterior mitral leaﬂet
(PML), and the nadirs, which are located close to the
ﬁbrous trigones.TABLE 1 Anatomical Nomenclature and Deﬁnitions for Annular Quan
Anatomical Entity Alternative Descriptor
Posterior MA PML insertion Ins
Anterior MA Anterior peak, aortic peak Am
Intervalvular ﬁbrosa Aortomitral curtain (surgical),
aortomitral continuity,
aortomitral junction, ﬁbrous
continuity
Fib
Left trigone Lateral trigone An
Right trigone Medial trigone An
Trigone-to-trigone distance (TT) Intertrigonal distance Dis
Septal-to-lateral distance (SL) A2-to-P2 distance, anterior-
posterior distance
Dis
Commissure-to-commissural
distance (IC)
Intercommissural distance,
medial-to-lateral distance
Dis
Mitral annular trajectory Mitral annular axis Tra
Neo-LVOT Fo
MA ¼ mitral annulus; PML ¼ posterior mitral leaﬂet; LVOT ¼ left ventricular outﬂow trThe junction of the left atrium (LA), LV,
and PML insertion typically forms a well-
deﬁned, distinct ﬁbrous structure (14–16). In
contrast, the anterior annulus is more difﬁ-
cult to deﬁne, having various perspectives
among specialties and imaging modalities
(17–19), primarily due to the continuous
transition of the AML into the intervalvular
ﬁbrosa, also referred to as the “aortomitral
curtain” or “continuity.” Surgeons tend to
exclude the intervalvular ﬁbrosa from their
MA deﬁnition (18) as they can visually
identify the distal margin of left atrial
myocardium along the aortomitral curtain
intraoperatively. However, the intervalvular
ﬁbrosa is often included in cardiac imaging,
likely due to the lack of a distinct border on
both computed tomography (CT) and echo-
cardiography (Figures 3 and 4). Importantly,
the anterior MA does not correspond to the
hinge point of the AML, as the latter is located
further toward the ventricle, usually below the ﬁbrous
trigones.
MV LEAFLETS. The two MV leaﬂets are referred to
as “anterior” and “posterior.” However, due to the
oblique orientation of the mitral apparatus, relative
to the anatomical axes, the leaﬂets are oriented in a
more anterosuperior and posteroinferior position
(20). The leaﬂets are asymmetrical in shape, with the
AML being rounded and occupying a third of the
annular circumference, whereas the radially narrower
PML occupies the other two-thirds. The coaptationtiﬁcation
Deﬁnition
ertion of the PML, usually at the junction of the left atrium and left
ventricle
biguous deﬁnitions, e.g., identical with the insertion of the noncoronary
and left coronary cusp; or excluding the intervalvular ﬁbrosa
rous tissue between both trigones; toward the ventricle transitioning
into the AML; on the atrial side in parts covered by left atrial
myocardium; scaffold for the insertion of parts of the noncoronary and
left coronary cusp
chor for intervalvular ﬁbrosa
chor for intervalvular ﬁbrosa, continuous with semimembranous septum
tance between the left (lateral) and right (medial) trigones
tance between the annulus at A2 to the annulus at P2; for the D-shaped
concept between the trigone-to-trigone distance and P2 in a
perpendicular fashion
tance between annulus at P1 and P3 along the bi-commissural view; with
3D automated segmentation in a perpendicular fashion to the septal-to-
lateral distance through the centroid
jectory perpendicular to the annular plane
rmed by the deﬂected AML and basal septum after TMVI
act; TMVI ¼ transcatheter mitral valve implantation.
TABLE 2 Role and Contribution of Imaging Modalities in the Context of TMVI
Plan TTE
2D
TEE/X-Plane 3D* 3D TEE CT Fluoroscopy
Pre-procedural planning
Quantiﬁcation of MR þþþ þþ þþþ NA þ
Annular dimensions þ þ þþ þþþ NA
Leaﬂet morphology þþ þþþ þþþ þþ NA
Annular and leaﬂet
calciﬁcations
þþ þþ þ þþþ þ
Chordae þþ þþ þþ þ NA
Papillary muscle anatomy þþ þþ þþ þþþ NA
LV Size and function þþþ þþ NA þþ þþ
LVOT anatomy þ þþ þþþ þþþ NA
Periprocedural imaging
Localization of ventricular
puncture
NA þþþ* þ NA þ
Guidewire advancement
and positioning
NA þþ* þþþ† NA þþ
delivery system advancement
and positioning
NA þþþ* þþþ NA þþ
Device deployment NA þþþ* þþþ NA þþ
Rotational alignment NA þ§ þþþ†‡ NA þ
Device anchoring NA þþþ* þþ NA þ
Post-TMVR
Valvular competency/
para-valvular
regurgitation
þþ þþ þþþk þ þ
Trans-mitral gradient þþþ þþþ NA NA NA
LVOT anatomy þþ þþ þþþ þþþ NA
LVOT gradient þþþ þþ NA NA þþþ#
Device apposition/seating þþ þþ þþþ þþþ NA
Device stability þþþ þþþ þþ þþ þþþ
Leaﬂet mobility/thrombus þ þþþ þþ þþþ NA
Stent fracture NA NA NA þ þþþ
*X-plane mode. †Live 3D mode. ‡Zoom 3D mode. §Transgastric view. kColor 3D and vena contracta area.
#Catheter-based direct gradient measurement.
LV ¼ left ventricle; LVOT ¼ left ventricular outﬂow tract; MR ¼ mitral regurgitation; NA ¼ not applicable;
TMVI ¼ transcatheter mitral valve implantation.
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1194line approximates a semilunar arc, with each end
referred to as a “commissure.” Importantly, the
anterolateral and posteromedial commissures do not
extend to the annulus, often lacking a distinct sepa-
ration of both leaﬂets. The PML is indented by folds
or clefts, creating 3 frequently unequal scallops, with
the middle scallop being typically the largest. Car-
pentier’s nomenclature (21) describes the most
lateral, anterosuperior segment as P1, the central
segment as P2, and the most medial, posteroinferior
segment as P3. Although the indentations can be well
visualized on echocardiography, they are not as
discrete on CT, owing to partial volume averaging.
Thus, on CT the PML can be routinely subdivided into
3 equal partitions, P1, P2, and P3. The AML is curtain-
like and lacks distinct scallops, although similar
labeling (A1, A2, and A3) is applied to the lateral,
middle, and medial segments, respectively.ECHOCARDIOGRAPHIC IMAGE ACQUISITION. Alth-
ough echocardiography is the primary imaging mo-
dality for diagnosing and quantifying MR, this paper
focuses on pre-procedural anatomical assessment,
intraoperative guidance, and post-operative assess-
ment (Table 2).
The mitral apparatus can be imaged on both
transesophageal echocardiography (TEE) and trans-
thoracic echocardiography (TTE). On TTE, the A2-P2
scallops are typically imaged from either parasternal
or apical long-axis views. Inferomedial and antero-
lateral tilting of the image plane may allow imaging of
the A1-P1 or A3-P3 coaptation. The apical 4-chamber
view illustrates the A3-A2 scallops medially and the
P2-P1 scallops laterally, whereas the commissural
view images P3-A2-P1. The basal short axis view of
the MV shows all 6 mitral valve scallops and both
commissures, with A1-P1 scallops typically located to
the right of the image. In addition, short-axis views
may provide the best imaging planes for identifying
the location, number, and orientation of the papillary
muscles and attached chordae.
Current TEE guidelines recommend assessment
using standardized 2D views of the mitral valve
(4-chamber, 3-chamber, commissural) from a mid-
esophageal position and transgastric views as well as
3D imaging planes (22). Generally, imaging protocols
should be adapted to the individual patient’s heart
by using rotational angles that optimize the recording
of important structural and ﬂow information.
3D echocardiography (23) has a variety of 3D
acquisition modes and display options (simul-
taneous multiplane imaging, tomographic slices,
surface rendering, and volume rendering). In addi-
tion, it allows for simultaneous multiplane imaging
(“x-plane mode”) with 2D planes in a modiﬁable
angulation to each other. Multiplanar reconstruction
of the 3D volume allows for anatomical measure-
ments. Importantly, real-time volume rendering per-
mits construction of an en face atrial view known as
the surgical view. The ventricular perspective can be
important in assessing subvalvular structures and
LVOT evaluation. 3D TEE usually produces images
with spatial resolution that is superior to that of
3D TTE. For TMVI, 3D TEE is most useful for
anatomical assessment, quantiﬁcation, and intra-
procedural guidance, in particular by providing a
“surgical” view.
3D TEE images can be acquired using different
acquisition volumes as well as either single-beat or
multibeat datasets (23). Multibeat acquisitions
improve temporal and spatial resolution but may be
limited by “stitch artifacts” due to irregular rhythm or
respiratory variations. Multicycle acquisitions are
CENTRAL ILLUSTRATION Multimodality Imaging for TMVI: Pre-Procedural Screening, Periprocedural Guidance and
Post-Procedural Assessment
Overview of the contribution of computed tomography (CT), transesophageal echocardiography (TEE), transthoracic echocardiography (TTE), and ﬂuoroscopy in the
context of transcatheter mitral valve implantation (TMVI). AML ¼ anterior mitral valve leaﬂet; IC ¼ intercommissural; LVOT ¼ left ventricular outﬂow tract; PML ¼
posterior mitral leaﬂet; SL ¼ septal-to-lateral; TT ¼ trigone-to-trigone.
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FIGURE 1 Schematic of Various TMVI Anchoring Mechanisms
(A) Baseline anatomy. (B) Anchoring with tabs, for example, posteriorly (inferolateral) at a
myocardial shelf and anteriorly at the ﬁbrous trigones. (C) Anchoring by grasping the AML
and PML with paddles. (D) Barbs. (E) Anchoring to the apical myocardium with a tether
(neochord). AML ¼ anterior mitral valve leaﬂet; LA ¼ left atrium; LV ¼ left ventricle;
PML ¼ posterior mitral leaﬂet; TMVI ¼ transcatheter mitral valve implantation.
FIGURE 2 Transca
(A) Tiara (courtesy o
FORTIS Transcathete
(C) Tendyne transcat
ings, Roseville, Minn
Mitral Valve Implant
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1196usually needed to present 3D color images with
adequate temporal resolution.
The narrow-angle “live” 3D mode allows for “real-
time” 3D images, using a single-beat mode and
a matrix array transducer display of a relatively
narrow-angle pyramidal volume, which is usually
insufﬁcient to visualize the entire mitral apparatus.theter Mitral Valves Currently in Human Trials
f Neovasc Inc., Richmond, British Columbia, Canada). (B) Edwards
r Mitral Valve (courtesy of Edwards Lifesciences, Irvine, California).
heter mitral valve implantation system (courtesy of Tendyne Hold-
esota). (D) CardiAQ Valve Technologies System for Transcatheter
ation (courtesy of CardiAQ Valve Technologies, Irvine, California).This is most useful for focusing on a speciﬁc
abnormality in the mitral valve once orientation is
clear. It is extensively used live to guide device
deployment.
The wide-angle 3D mode with a focused wide
sector (zoom 3D) permits a wide sector view of the MV
apparatus from the annulus to the papillary tips. The
broader sector mode is associated with inferior spatial
and temporal resolution compared to the “live”
mode.
The full volume mode has the largest acquisition
sector, which is ideal for imaging the entire mitral
apparatus together with the LV. This mode also has
optimal spatial and temporal resolution, permitting
detailed diagnosis of complex pathologies but is
ideally used with multiple cycle acquisitions.
CT DATA ACQUISITION AND
RECONSTRUCTION
Given dynamic changes in anatomical conﬁgura-
tion of the mitral apparatus, LVOT, and LV,
contrast-enhanced CT data acquisition for TMVI
should preferably image the entire cardiac cycle
(24), for example, by means of retrospectively
electrocardiography-gated data acquisition, or by
prospective electrocardiography-triggered data ac-
quisition with “whole-heart” detector coverage (25).
Image acquisition can be limited to the heart; how-
ever, imaging of the entire thoracic cage may be
beneﬁcial to determine the intercostal space for
transapical access. Except for annular measure-
ments, the mitral apparatus is best evaluated by
standard views mimicking those obtained using
echocardiography (commissural, 3-chamber, 4-chamber,
and short-axis views) (Figure 3).
2D ANNULAR ASSESSMENT
On 2D echocardiography, the MA was traditionally
assessed on a “view-based” approach, using 2- and
4-chamber views (26), aiming to align the mitral
apparatus with the cardiac chambers while uninten-
tionally disregarding the noncircular MA geometry.
Correct anatomic imaging planes using a true
commissural view showing the P1-A2-P3 scallops and
a perpendicular on-axis long-axis view depicting the
A2-P2 scallops have been proposed for more adequate
assessment (17,27), and can also be mimicked on CT.
Although the commissural and long-axis views pro-
vide the major and minor MA diameter, respectively,
2D measurements overall incompletely describe the
complex 3D MA geometry, and yielded values are
strongly dependent on their exact orientation (17,27).
FIGURE 3 2D Multiplanar Cardiac CT Views
Short-axis view of the MA region (A) and schematic of the leaﬂet scallops (B) with dashed
lines indicating the orientation of the views in D to F. (D) Commissural view transecting at
P1-P3 (major MA diameter). (E) Long-axis view transecting through A2-P2, oriented
perpendicularly to the commissural view. The long-axis view is lacking a distinct MA
landmark at A2, resulting in variable measurements (C, inset). (F) Four-chamber view with
a diagonal orientation (not recommended for 2D measurements). 2D ¼ two-dimensional;
CT ¼ computed tomography; LAA ¼ left atrial appendage; LAX ¼ long-axis; MA ¼ mitral
annulus.
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1197For 2D TEE, the variability of imaging planes for
any individual is signiﬁcant, and even with probe
manipulation, optimal visualization of the annular
plane cannot be guaranteed. Importantly, there is
controversy regarding the deﬁnition of the anterior
MA (Figure 4). Some deﬁne it as identical to the
insertion of the non- and left-coronary aortic cusps
including the intervalvular ﬁbrosa, whereas others
deliberately exclude the latter, with the lack of a
distinct border to the AML creating further confusion.
Overall, these limitations challenge the applicability
of 2D echocardiographic and CT measurements for
TMVI planning (22,27–30).
3D ANNULAR SEGMENTATION
3D segmentation on 3D echocardiography and CT
overcomes these aforementioned limitations. 3D MA
segmentation was ﬁrst described by Levine et al.
(13,31) using 2D echocardiography and has been reit-
erated with modern imaging technologies (32,33).
With contemporary approaches, segmentation is
performed by generating a cubic spline interpola-
tion of manually placed seeding points along the
3D annular contour. However, until recently, MA
segmentation has largely been of academic interest,
with surgical sizing performed at the time of the
procedure in a nonstandardized fashion (18).
Increasing interest in minimally invasive mitral
procedures has triggered development of post-
processing solutions for 3D annular segmentation for
both echocardiography and CT, permitting assess-
ment of area, perimeter, and other salient measure-
ments. The so-called method of “least squares planes”
provides the mathematical foundation for deriving 2D
measurements from the 3D contour by deﬁning a 2D
plane and the geometrical center, referred to as the
centroid (34,35). Simpliﬁed, this can be illustrated by
projecting the 3D contour onto a 2D plane (Figure 5).
This method also permits deﬁnition of an axis that
is oriented perpendicularly to the 2D plane while
transecting the centroid.
We propose that the 2D plane derived from the
3D contour is referred to as the “MA plane” and that
the aforementioned axis is referred to as the “MA
trajectory.”
As previously discussed, it has been well estab-
lished that the MA is nonplanar (13). However, for
TMVI planning, truncation of the saddle-shaped
annular contour at a virtual line connecting both
trigones, referred to as the trigone-to-trigone (TT)
distance, has been proposed (10), based on the
observation that the anterior horn of the saddle-
shaped contour would otherwise project into theLVOT (Figure 6). The resulting D-shaped MA is more
planar and does not project onto the LVOT.
On cardiac CT, 3D segmentation is performed by
placing seeding points for the cubic spline along the
insertion of the PML, using long- and short-axis
reformats aligned with the LV long axis (Figure 6).
The anterior horn is segmented along the insertion of
the noncoronary and right coronary aortic cusp into
the intervalvular ﬁbrosa. After identifying the trig-
ones, the anterior horn is truncated along the TT
distance to form the D shape (36). Post-processing
yields annular area and perimeter, the latter consist-
ing of the posterior annulus (PML insertion) and the
TT distance. Furthermore, annular geometry is char-
acterized by measurement of the septal-to-lateral
(SL) distance (A2-to-P2 distance, minor diameter),
and the intercommissural (IC) distance (major diam-
eter). For standardization and because of the arc-
shaped coaptation zone, we recommend that the IC
distance be assessed in a parallel fashion to the TT
distance, while transecting through the centroid of
the D-shaped annulus, usually yielding the largest
FIGURE 5 3D MA and 2D Projected Contour
The 2D MA area is assessed using the method of least squares,
similar to projecting the contour onto a plane. Orientation of the
plane and MA trajectory are obtained by the least squares plane
calculation. The actual 2D MA plane has the identical orientation
as the projection but transects through the geometrical centroid.
FIGURE 4 2D Cardiac Views and MA Measurements in TEE
Commissural view transecting the annulus at P1-P3, typically
yielding the major MA diameter (A). Perpendicular long-axis view
transecting at A2-P2 (B), yielding the minor MA diameter. In
contrast to P1-P3, there is no distinct landmark at A2 deﬁning the
anterior annulus. TEE ¼ transesophageal echocardiography;
other abbreviations as in Figure 3.
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1198long-axis dimension. Similarly, the SL distance
should be assessed perpendicularly to TT and IC dis-
tances while transecting through the centroid
(Figure 6E).
Similar post-processing can be performed off-line,
using echocardiographic 3D volume sets (Figure 7).
For both CT and echocardiography, multiphasic
measurements can be performed to characterize the
dynamics of the MV complex.
FURTHER ANATOMICAL QUANTIFICATION
Leaﬂet anatomy and length are important for devices
anchoring to the leaﬂets themselves (8). Leaﬂet
length can be assessed on a 3-chamber view on both
echocardiography and CT by using mid-diastolic
caliper measurements. Adequate distance of the
papillary muscle tip to the leaﬂet is important fordevices that anchor behind the leaﬂets or at the
trigones to ensure sufﬁcient space for the tabs to
pass (7). Furthermore, anatomy should be assessed
for the presence of direct papillary muscle insertion
into the leaﬂets, which may interfere with anchoring
(Figure 8).
ANNULAR AND LANDING ZONE GEOMETRY
Normative data for mitral annular dimensions vary
widely, mainly because of differences in imaging
modalities and segmentation techniques, particularly
with regard to the anterior horn. Early 2D TTE studies
reported relatively smaller MA areas in normal
structures (37) than those in more recent studies us-
ing 3D echocardiographic techniques, which report
mean values ranging between 8.4 cm2 and 11.8 cm2
(34,38,39), with comparable values reported in car-
diac CT studies among control cohorts (24,39–42). In a
recent investigation using the aforementioned deﬁ-
nition of the D-shaped annulus, mean MA area was
8.9  1.5 cm2 in control subjects without signiﬁcant
cardiovascular disease, with broad interindividual
variation noted and larger dimensions observed in
males due primarily to differences in body size
(39,43). Mean MA dimensions are increased in TMVI
patients, with mitral valve prolapse being associated
with larger mean dimensions than FMR (40,41,43,44).
In FMR, the saddle height decreases, resulting in a
more planar saddle-shaped annular contour (34);
however, this does not affect the already more planar
D-shaped annular segmentation (10). In regard to in-
plane geometry, relatively greater enlargement of
the SL distance than the IC distance is observed
FIGURE 6 3D-Mitral Annular Segmentation on CT
(A) Saddle-shaped MA segmentation as a cubic spline interpolation. (B) Pink line ¼
anterior peak; red line ¼ posterior peak (PML insertion); green and blue dots ¼ ﬁbrous
trigones. Importantly, the anterior peak projects into the LVOT (short-axis view [C] and
long-axis view [D]). The more planar D-shaped annular contour is created by truncating
the saddle-shaped contour at the trigone-to-trigone distance (yellow lines [E and F]).
Important measurements are the projected area septal-to-lateral (SL) and inter-
commissural (IC) distances; the latter is oriented perpendicularly to SL while transecting
through the centroid (F). Abbreviations as in Figures 1 and 3.
FIGURE 7 3D Mitral Annular Segmentation on 3D TEE
Multiplanar reformatting of the 3D TEE dataset with annular contour and segmented
coaptation line. (A) Commissural view. (B) Long-axis view perpendicular to A at A2-P2
(septal-to-lateral). (C) Short-axis view. (D) Surgical view.
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1199in both FMR and mitral valve prolapse patients
(40,41,43).
Importantly, landing zone anatomy varies between
FMR and mitral valve prolapse. In FMR, regional wall
motion abnormalities and/or LV dilation leads to se-
vere tethering of mitral leaﬂets and annular dilation,
resulting in not only increased tenting height and
reduced coaptation length (43) but also remodeling of
the basal myocardium with formation of a “myocar-
dial shelf,” which can be identiﬁed on both echocar-
diography and CT (Figures 9C and 9F). In DMVD with
ﬁbroelastic deﬁciency characterized by single-scallop
prolapse with other scallops/leaﬂets often normal or
thin and diffuse myxomatous degeneration, with
generalized valvular thickening, redundant leaﬂets,
and chordal elongations, the insertion of the mitral
valve leaﬂet may be displaced into the LA (Figures 9B
and 9E), referred to as mitral annular disjunction
(14,45). In DMVD, a posterior “myocardial shelf” is
typically not present, and the basal myocardium may
bulge into the lumen with hyperdynamic and hyper-
trophied LV anatomy.
MITRAL ANNULAR DYNAMICS
Although minimal MA dimensions are present in early
systole, MA dimensions increase toward late systole
(38,44,46). Importantly, annular dynamics differ be-
tween normal subjects and patients with mitral valve
disease. In FMR, the extent of dynamic changes is
generally diminished (24,46,47), whereas more pro-
nounced changes have been described in DMVD
(44,46), with loss of systolic area contraction as well
as signiﬁcant increase in annular area from early to
late systole. However, recent evidence suggests that
relevant differences exist between the ﬁbroelastic
deﬁciency and diffuse myxomatous degeneration
phenotypes, with abnormal dynamics observed only
in diffuse myxomatous degeneration (48). The po-
tential for changes in MA dimensions emphasizes the
importance of multiphasic annular measurements for
TMVI planning.
ANNULAR CALCIFICATION
Mitral annular calciﬁcation (MAC) is a common
degenerative process of the ﬁbrous MA associated
with advancing age (49,50) and end-stage renal dis-
ease (51) and is present in approximately 6% of the
general population (52). Due to the high prevalence of
both MR and MAC, these entities may coincide
without necessarily being causally related to each
other. The extent of MAC can vary from mild and
spotty involvement to severe, calciﬁc encasement of
FIGURE 8 Assessment of Papillary Muscle Anatomy
(A) Distance measurement from the anteromedial papillary
muscle tip to the annular plane (yellow line). The red line
indicates the annular trajectory. (B and C) Multiplanar reformat
and endovascular volume rendered image demonstrating direct
insertion of the anteromedial papillary muscle into the AML
(yellow arrow in B, black arrow in C). Abbreviations as in
Figure 1.
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1200the entire annulus, although it is frequently limited to
the posterior part. A rare variant of MAC is caseous
annular calciﬁcation, which forms bulky, space-
occupying lesions predominantly along the posterior
annulus (53). Compared to typical MAC, caseous MAC
is less echodense and may exhibit homogenous
areas of attenuation similar to the contrast-enhanced
blood on contrast-enhanced CT but can be well
distinguished on non–contrast-enhanced CT (54). The
relevance of MAC is currently unknown, although it is
a contraindication to TMVI if it is severe in most of
the current feasibility studies.
DETERMINATION OF TMVI FEASIBILITY WITH
MULTIMODALITY IMAGING
The relevant anatomy for determination of TMVI
feasibility depends on which device is beingimplanted, given the interdevice variations in
anchoring mechanisms. TMVI devices require proper
sizing of the MA as well as a detailed characterization
of the landing zone. Because of dynamic changes,
annular dimensions should be assessed at multiple
phases throughout the cardiac cycle. Excessive MAC
or subvalvular calciﬁcation could interfere with
proper seating and apposition.
Furthermore, anatomical suitability of the an-
choring mechanism should be assessed. For devices
anchoring onto the leaﬂets with paddles (8), for
example, at A2-P2, ensuring sufﬁcient leaﬂet length
and ruling out MV prolapse and annular disjunction
at P2 are required. Importantly, papillary muscle
and chordae anatomy should be assessed for the
presence of false bands and direct insertion of
papillary muscles. For devices anchoring with tabs in
the inferolateral basal myocardium (7), the presence
of a “myocardial shelf” that persists throughout the
cardiac cycle should be ensured. Hypertrophy of the
basal myocardium with a myocardial bulge or severe,
bulky annular calciﬁcation may interfere with this
particular anchoring mechanism. Devices anchoring
by an apical tether are not affected by leaﬂet
length or pathology (6). For all TMVI devices, the
basal LV cavity must be able to accommodate the
device, and small LV cavities with hyperdynamic
function may not necessarily allow room for the
TMVI cage.
PREDICTING LVOT OBSTRUCTION
TMVI devices consist of circumferentially covered
stent struts (7,8,55) that may signiﬁcantly protrude
into the LV cavity, interact with the AML, and
potentially encroach upon the LVOT. Because of this
protrusion, a neo-LVOT is created by the device, the
AML, and the interventricular septum. Theoretically,
LVOT obstruction can occur due to narrowing of the
native LVOT above the level of the TT line or to for-
mation of a narrow neo-LVOT below the level of the
TT line toward the LV.
Predisposing factors for LVOT obstruction include
anatomical and device-related factors. LVOT anat-
omy exhibits signiﬁcant interindividual variability
and is inﬂuenced mainly by conﬁguration of the
interventricular septum, LV size, and aortomitral
angulation. In particular, a hypertrophied, bulging
septum reduces the LVOT and neo-LVOT cross-
sectional areas.
AORTOMITRAL ANGULATION. Aortomitral angula-
tion is the angle between the MA trajectory and the
LVOT long axis. Theoretically, a parallel orientation
of the MA trajectory and the LVOT long axis would
FIGURE 9 MA Landing Zone in Normal, DMVD, and FMR
(A to C) TEE and (D to F) corresponding multiplanar CT images. Normal 4-chamber-view
annular anatomy is shown (A and D). In mitral valve prolapse MA disjunction (MAd) may be
observed (B andE) in 4-chamber views. In FMRwithLVdilation amyocardial shelf is observed
along the posterior annulus (commissural views [C and F]). DMVD ¼ degenerative mitral
valve disease; FMR¼ functional mitral regurgitation; other abbreviations as in Figures 1 and
3.
FIGURE 10 Prediction of Neo-LVOT Dimensions
End-systolic CT-datasets in FMRwith an anterolateral/lateral myocardial scar (A, C, E) and in
DMVD (B, D, E). (A andB) Three-chamber views and commisural views (C andD) showing the
annular segementation and a simulated cylindrical device (29mm), oriented perpendicularly
to the annular plane. The neo-LVOT formed by the septal myocardium and the device is
segmented (center line technique, orange line). The red bar indicates the position of the
short-axis LVOT view (E and F), which allows for planimetric assessment of the neo-LVOT,
yielding 3.5 cm2 at end-systole (E), indicating low risk for LVOT obstruction, and a slit-like
neo-LVOT (F) suggests high risk for LVOT obstruction. LVOT¼ left ventricular outﬂow tract.
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1201result in minimal risk of LVOT obstruction, whereas a
perpendicular orientation would result in maximal
risk. Aortomitral angulation must be viewed in the
context of LVOT and LV dimensions and septal
anatomy rather than as a single, stand-alone factor.
Furthermore, quantiﬁcation may be limited by sub-
jective assessment of the LVOT long axis.
LV SIZE. A small LV cavity is a known risk factor
for LVOT obstruction after surgical valve replace-
ment, with a larger LV cavity likely to be able to
accommodate a device without compromising the
LVOT. However, the speciﬁc LV anatomy needs
to be considered. In FMR, the LV may be glo-
bally dilated or focally scarred with compensatory
hypertrophy of other myocardial segments. Con-
versely DMVD patients with hyperdynamic systolic
LV function may exhibit small end-systolic LV
diameters (56).
INTERVENTRICULAR SEPTUM. Similarly, basal septal
bulging or basal hypertrophy (>15 mm) may signif-
icantly decrease neo-LVOT dimensions and is a
known risk factor for systolic anterior motion of
the AML in surgical MV repair. Septal hypertrophy
is often associated with increased aortomitral
angulation, further increasing the LVOT obstruction
risk.
DEVICE-RELATED FACTORS AND SIMULATION OF
DEVICE IMPLANTATION. Device protrusion into the
LV and device ﬂaring are determinants of neo-LVOT
geometry, with higher risk associated with more
protrusion and device ﬂaring.
CT TMVI simulation may predict neo-LVOT geom-
etry by embedding a cylindrical or device-speciﬁc
contour into the CT dataset, followed by segmenta-
tion and planimetrical assessment of the neo-LVOT
cross-sectional area (Figure 10). This virtual assess-
ment is somewhat limited, however, as there are no
established cutoff values for minimal neo-LVOT area
that indicate an increased risk of LVOT obstruction.
First, studies have been limited to patients with hy-
pertrophic obstructive cardiomyopathy, in whom the
risk of developing a gradient of >50 mm Hg has been
shown to correspond with LVOT area cutoffs ranging
from 0.85 to 2.0 cm2 (57,58). Second, the appropriate
cardiac phase for assessment is unknown. Neo-LVOT
dimensions appear worse at end-systole, but the
ventricular stroke volume is already ejected at
this time point, suggesting greater importance of
assessment in early or mid-systole. Third, the AML
may contribute to LVOT obstruction due to displace-
ment by the device and systolic anterior motion.
Although redundant AML tissue may be noticed on
FIGURE 11 Transapical Access Point
The annular trajectory (light blue) is oriented perpendicularly to the annular plane, which
is discrepant to the line connecting the centroid and true LV apex (purple line). The ideal
access point can be assessed on volume-rendered images. (A) Long-axis view. (B) Volume-
rendered image in true anterior-posterior orientation. (C) Schematic view. (D) Volume-
rendered image viewed from LAO 45 and CRA 25. CRA ¼ cranial; D2 ¼ second diagonal
branch; LAD ¼ left anterior descending artery; LAO ¼ left anterior oblique.
FIGURE 12 Assess
The annular trajecto
can be assessed in re
Volume-rendered im
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1202echocardiography and CT, device simulation does not
factor in AML behavior post-implantation. Fourth, LV
and neo-LVOT dimensions will signiﬁcantly depend
on the hemodynamic state and can be altered by
exertion and LV remodeling.ment of Transapical Approach
ry (light blue) and connection line to the true LV apex (purple line)
lation to the ribs, intercostal spaces, sternum, and midline. (A)
age shows trajectories and rib cage. (B) Surface rendering illustrates
e sternum and midline. (C) Axial view with curved distance mea-
he access point and midline.DETERMINING ACCESS LOCATION
The MA trajectory oriented perpendicularly to the MA
plane represents the ideal delivery path to facilitate
coaxial device deployment. By extending the MA
trajectory beyond the epicardium on post-processing,
the ideal LV access point can be identiﬁed, which
is commonly located laterally or anteriorly to the
true apex (Figure 11). Once identiﬁed, CT simulation
shows the trajectory’s relationship to the coronary
arteries, papillary muscles, or myocardial scars and
provides the distance to the MA plane for intra-
procedural guidance. Further extension of the tra-
jectory beyond the body surface can help determine
the ideal intercostal space and distance from the
sternal midline (Figure 12). By creating an en face
view, the orientation of the MA trajectory, commonly
pointing to the left anterior oblique and caudally, can
be provided to facilitate alignment of the delivery
system with the trajectory for coaxial deployment
(Figure 13C).
PRE-OPERATIVE PREDICTIONS OF
FLUOROSCOPIC ANGULATIONS
Device advancement, unsheathing, and release are
monitored by ﬂuoroscopy (Figure 14). Similar to TAVR,
coplanar ﬂuoroscopic projections facilitate coaxial
device deployment. MA plane segmentation on CT can
provide projection angulations yielding an optimal
viewing curve, displaying the corresponding cranial-
caudal angulation for a given LAO/RAO angulation
(Figure 13). Secondary to relatively vertical position of
the MA, these curves exhibit a steep slope with pro-
nounced changes in cranial/caudal angulation for
small changes in RAO angulation. In addition to
being orthogonal to the MA, TMVI requires C-arm
projections aligned with speciﬁc anatomical and
anchoring structures. Given the asymmetrical MA,
2 views are intuitive: the septal-to-lateral view
parallel to the SL line (A2-P2 view) and the TT view
parallel to the TT line. However, projection angula-
tions are limited by physical restraints of the C-arm
and required procedural access. Angulations required
to achieve the SL view are generally in the range
of practical C-arm working angles, whereas angula-
tions for the TT view are not (11). Alternatively, a
compromise view between the TT view and SL
view has been shown to be effective during device
deployment (11).
The TMVI procedure is performed without angi-
ography, and the noncalciﬁed annulus lacks a ﬂuo-
roscopically identiﬁable anatomical landmark. An
indirect landmark can be created by using a coronary
FIGURE 13 Prediction of Fluoroscopy Angulation
(A) Short-axis view. (B) Optimal viewing curve. (C) En face view. (D and G) TT view. (E and H) Compromise view. (F and I) SL and A2-P2 views.
SL ¼ septal-to-lateral; TT ¼ trigone-to-trigone.
FIGURE 14 Intraoperative Fluoroscopy Guidance
Intraoperative ﬂuoroscopy shows partial deployment of a Tiara
device (Neovasc Inc.) with coplanar depiction of the transapical
delivery system, evident by the linear appearance of the circular
marker. A transjugular coronary sinus wire serves as an
anatomical landmark.
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1203sinus guidewire (11). Using a transjugular approach,
the guide wire usually follows the ﬂoor of the coro-
nary sinus at P1 to then align with the outer curvature
at P2. Given the signiﬁcant interindividual variability,
with the sinus often located distant to the annular
plane along the left atrium (59,60), this individual
path can be predicted pre-procedurally by using the
CT dataset (Figure 15), allowing for guidewire simu-
lation in relation to the annular plane in any ﬂuoro-
scopic view (11).
GENERAL PRINCIPLES OF
DEVICE IMPLANTATION AND
INTRAPROCEDURAL IMAGING
Intraprocedural imaging is performed with TEE
(Online Videos 1 and 2 [videos are courtesy
of Tendyne Holdings, Roseville, Minnesota]) and
ﬂuoroscopy (Table 2). The location of the ventricular
puncture can be conﬁrmed on TEE by “poking” the
LV with a ﬁnger at the intended cannulation
site (Figure 16), ideally using standardized views,
FIGURE 16 Localiz
(A) Simultaneous mu
intended cannulation
FIGURE 15 Coronary Sinus Segmentation
Spline segmentation along the outer curvature beginning at P2. (A and B) Short- and long-
axis views, respectively, and subsequent angiographic simulation (C), illustrating the
relationship between the potential coronary sinus wire and the annular plane.
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1204comparable to the previous CT simulation, aiming at
following the MA trajectory but staying away from the
papillary muscles, septum, and right ventricular
apex. Continuous imaging of the guidewire is per-
formed to determine the correct placement across theing the Apical Cannulation Site
ltiplane image showing the surgeon’s ﬁnger (red star) poking the
site. (B) Initial wire path (yellow dotted line).MA and positioning in the right pulmonary vein, us-
ing ﬂuoroscopy and TEE. To ensure that the wire does
not pass through the chordae, an inﬂated balloon
catheter may be advanced into the left atrium and
pulled back under TEE, ﬂuoroscopic, and tactile sur-
veillance. At this stage, C-arm angulation already
provides either a SL/A2-P2 or a compromise view
along the optimal viewing curve, as proposed
by prior CT-analysis, allowing for a coplanar depic-
tion of the delivery system if aligned with the MA
trajectory. The delivery system is introduced under
both ﬂuoroscopic and TEE guidance, again conﬁrming
free passage from the apex to the left atrium and
excluding entanglement of the device in the sub-
valvular apparatus by moving the device in the MV
oriﬁce.
Depending on device design, device unsheathing
and unfolding begins either above or at the annular
level. Centering of the delivery system in the mitral
oriﬁce at A2-P2 is guided by TEE, using either a 3D
en face surgical view or a multiplane 2D view, such
as simultaneous long-axis and commissural views,
or deep gastric short-axis views, especially if 3D
views are suboptimal. The x-plane function is most
useful for centering and determining the degree of
advancement with respect to the annulus, whereas
the en face 3D view is helpful for judging rotational
alignment, although in practice, both functions are
often interchanged rapidly. Unfolding of the atrial
ﬂange/skirt is monitored on both ﬂuoroscopy and
echocardiography. Continuous monitoring of the
orientation with appropriate rotational adjust-
ment can be performed throughout the deployment
process, ensuring alignment of the ﬂat portion of
D-shaped devices or speciﬁc anchoring mechanism
with the mitral apparatus.
A coronary sinus wire may aid estimation of the
device’s position in relation to the annular plane on
ﬂuoroscopy by mentally integrating the distance of
the coronary sinus to the MA plane from prior CT
analysis. Furthermore, ﬂuoroscopy can show changes
in the atrial skirt conﬁguration, when the partially
unfolded device is lowered toward the annular plane,
supported further by tactile feedback. Atrial skirt
apposition to the atrial wall is documented on TEE,
typically using the x-plane mode with the long-axis
view as the primary view and the commissural view
as the secondary view. These views and the ability to
change the orientation of the secondary view may
allow rapid imaging of anchoring mechanisms prior to
release of the device. Devices anchoring to the MV
leaﬂets with paddles (8) require synchronous capture
of the AML and PML at A2 and P2 before the main
body is unsheathed. Correct paddle orientation and
FIGURE 17 Periprocedural TEE Imaging During TMVI With the Fortis Device
The treatment of severe mitral regurgitation (A) with TMVI (B-G). Anchoring paddles are initially positioned outside the leaﬂets (C), aligned at
A2-P2 using a short-axis gastric view (D). Leaﬂets are captured between the paddles and valve body, and the atrial ﬂange is released (E),
followed by deployment of the valve and sealing of the atrial skirt (F and G), leading to resolution of mitral regurgitation (H). Abbreviations as
in Figures 1 and 4.
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1205centered position at A2-P2 must be conﬁrmed on
x-plane or 2D transgastric short-axis views. Appro-
priate leaﬂet capture and paddle insertion are
conﬁrmed on the long-axis view. Finally, further
unsheathing of the main body is monitored on both
TEE and ﬂuoroscopy (intraprocedural examples are
shown in Figures 17 and 18).
POST-TMVI ECHOCARDIOGRAPHIC
ASSESSMENT
Immediately following deployment, 2D and 3D im-
aging conﬁrm appropriate seating, stability, radial
orientation, relationship to the captured leaﬂets, and
prosthetic valve function. Comprehensive 2D and 3D
assessments of the LVOT are performed by using co-
lor, pulsed and continuous wave Doppler to exclude
potential LVOT obstruction. The transgastric window
can be used to measure LVOT velocities.
Color Doppler is used to assess central or para-
valvular mitral regurgitation (Figure 19). Qualitativeand semiquantitative methods of assessing para-
valvular mitral regurgitation have been reported
previously (61). Assessment may be complicated
by device-related acoustic shadowing and irregular
or atypical regurgitant jets. Here, TEE is likely
to be more sensitive than TTE. However, adjudication
of paravalvular mitral regurgitation severity may
be difﬁcult due to the variability and complexity
of oriﬁce geometry and absence of a true gold stan-
dard. Therefore, incorporation of other methods,
such as pulmonary venous ﬂow pattern (“systolic
blunting/reversal”) and LVOT-to-transmitral velocity
time integrals ratio (as a surrogate for mitral regur-
gitant volume) may be helpful (61). Although data are
presently lacking, assessment of paravalvular mitral
regurgitation severity by 3D vena contracta area
seems likely to have an increasing role.
Mitral valve oriﬁce area can be quantiﬁed by direct
planimetry or by using Doppler and the continuity
equation (usually by TTE), which is preferred in the
absence of signiﬁcant mitral regurgitation. Although
FIGURE 18 Deployment of Tendyne Valve Using 3D Zoom Surgical Views
(A) Sheath (arrow) is seen in the LA above native leaﬂets. (B) Valve ﬂange (arrow) is
released and begins to appear in LA. (C) Valve ﬂange is rotated, aligning the ﬂat part of the
D-shaped mitral annulus with the aortic-mitral curtain (arrows). (D) Flange is fully opened,
and the bioprosthesis is seen in the center. Online Videos 1 and 2. Abbreviations as in
Figure 1.
FIGURE 19 TEE Images Immediately After Implantation of Tendyne Valve
X-plane view shows mid-commissural (A) and long-axis (B) views. Valve leaﬂets are in
closed position (mid-systole). Color Doppler images in same views showing LVOT pres-
ervation and no paravalvular leakage (C and D). Abbreviations as in Figures 4 and 10.
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1206a signiﬁcantly prolonged pressure half-time may
indicate valve stenosis, this method has limitations,
given the potential impact of variable LV and LA
compliance on the pressure decay slope and should
not be used to report valve areas (61).
FOLLOW-UP ECHOCARDIOGRAPHIC
IMAGING
TTE is convenient for evaluation of TMVI devices
over time. Apical views allow assessment of LV
volumes, LVEF, and global longitudinal strain and
strain rate to assess reverse remodeling and im-
provement of LV systolic function after TMVI. They
also allow accurate assessment of mitral valve gra-
dients and calculation of the LVOT/mitral inﬂow
VTI ratio. In contrast, TTE imaging of the left atrium
may be challenging due to acoustic shadowing,
making it difﬁcult to evaluate changes in LA volumes
or paravalvular leaks, especially from the apical
windows.
FUTURE DIRECTIONS
Pre-procedural imaging aids primarily in deter-
mining patient eligibility and device sizing. In
particular, prediction of LVOT obstruction may
require image analysis beyond merely device simu-
lation, especially in borderline situations. Here,
computational ﬂuid dynamics may provide more
insight but must also integrate dynamic changes of
LVOT anatomy.
Similar to that from TAVR, information derived
from CT is currently mentally integrated into the
procedure, in particular for optimizing ﬂuoroscopic
projections and access of the delivery system.
Although attempts have been made to fuse CT data
and ﬂuoroscopic images, major limitations will
consist of discrepant patient positioning and
anatomical distortion during apical access. Instead,
fusion of TEE and ﬂuoroscopy appears more
appealing and is of greater relevance, in particular
in regard to device positioning within the mitral
apparatus.
CONCLUSIONS
TMVI is an evolving treatment strategy for patients
with mitral regurgitation, requiring elaborate pre-
procedural and periprocedural imaging. CT and 3D
echocardiography aid in determining patient suit-
ability by 3D anatomical quantiﬁcation, landing zone
characterization, and TMVI simulation to identify
patients at increased risk for LVOT obstruction.
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1207Additionally, CT provides ﬂuoroscopy angulation and
the most suitable ventricular access site to allow for
coaxial deployment. Both 2D and 3D TEE guide the
procedure in conjunction with ﬂuoroscopy. Involve-
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